At EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S., we have a long-standing legacy of making a difference in the lives of patients and their loved ones. Helping to create, improve and prolong lives fuels our passion.
Building on deep expertise in neurology, fertility and endocrinology, we have a strong pipeline with more than 20 projects in development, including potential new oncology and immuno-oncology medicines as well as therapeutic options for psoriasis, lupus, multiple sclerosis, and other autoimmune diseases.
EMD Serono’s experience and scientific discoveries in MS date back more than 20 years. We have an ongoing commitment to improving the entire patient experience. To this end, we offer delivery devices for our therapeutic products as well as comprehensive patient education resources.
It is the people living with MS or those who will be diagnosed with MS, their caregivers and healthcare providers who have been our catalyst and inspiration to continue innovating, collaborating and advocating.